Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medical Research Methodology
Published in: BMC Medical Research Methodology 1/2020

01-12-2020 | Human Immunodeficiency Virus | Research article

Comparison of retention in observational cohorts and nested simulated HIV vaccine efficacy trials in the key populations in Uganda

Authors: Andrew Abaasa, Jim Todd, Stephen Nash, Yunia Mayanja, Pontiano Kaleebu, Patricia E. Fast, Matt Price

Published in: BMC Medical Research Methodology | Issue 1/2020

Login to get access

Abstract

Background

Outcomes in observational studies may not best estimate those expected in the HIV vaccine efficacy trials. We compared retention in Simulated HIV Vaccine Efficacy Trials (SiVETs) and observational cohorts drawn from two key populations in Uganda.

Methods

Two SiVETs were nested within two observational cohorts, one in Fisherfolk (FF) and another one in Female Sex Workers (FSW). Adult participants in each observational cohort were screened for enrolment into SiVETs. Those screened-out or not screened continued participation in the observational (non-SiVET) cohorts. SiVET participants were administered a licensed hepatitis B vaccine in a schedule that mimicked an actual HIV vaccine efficacy trial. Both cohorts were followed for 12 months and retention was assessed through dropout, defined as lost to follow up, being uncontactable, refusal to continue or missing the last study clinic visit. Dropout rates were compared using Poisson models giving rate ratios and 95% confidence intervals (95%CI).

Results

Out of 1525 participants (565 FF and 960 FSW), 572 (38%) were enrolled into SiVETs (282-FF and 290-FSW), and 953 (62%) remained in the non-SiVET cohorts. Overall, 326 (101 SiVET, 225 non-SiVET) dropped out in 1260 Person Years of Observation (PYO), a dropout rate of 25.9 /100 PYO (95%CI: 23.2–28.8); fewer dropped out in the SiVET cohorts (18.4, 95% CI: 15.1–22.4) than in the non-SiVET cohorts (31.6, 95% CI: 27.8–36.1), rate ratio (RR) =0.58, 95% CI: 0.46–0.73. In all cohorts, the dropout was more marked in FSW than in FF population. Duration lived in community was associated with dropout in both SiVETs and religion in both non-SiVET cohorts.

Conclusion

The rate of dropout was lower in SiVET compared to non-SiVET cohort. Though the difference in dropout between SiVET and non-SiVET was generally similar, the actual dropout rates were higher in the FSW population. Conduct of SiVETs in these key populations could mean that designing HIV Vaccine Efficacy Trials will benefit from lower dropout rate shown in SiVET than non-SiVET observational cohort.
Literature
1.
Development ICOAA. Understanding the research process for new HIV prevention technologies; 2010.
2.
UAC. Uganda national strategic plan for HIV&AIDS 2007/8–2011/12. 2007.
3.
Ruzagira E, Wandiembe S, Abaasa A, Levin J, Bwanika A, Bahemuka U, et al. Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda. PLoS One. 2011;6(6):e20684.CrossRefPubMedPubMedCentral
4.
Platt L, Grenfell P, Fletcher A, Sorhaindo A, Jolley E, Rhodes T, et al. Systematic review examining differences in HIV, sexually transmitted infections and health-related harms between migrant and non-migrant female sex workers. Sex Transm Infect. 2013;89(4):311–9.CrossRefPubMed
5.
Goldenberg SM, Strathdee SA, Perez-Rosales MD, Sued O. Mobility and HIV in Central America and Mexico: a critical review. J Immigr Minor Health. 2012;14(1):48–64.CrossRefPubMed
6.
Abaasa A, Asiki G, Mpendo J, Levin J, Seeley J, Nielsen L, et al. Factors associated with dropout in a long term observational cohort of fishing communities around Lake Victoria, Uganda. BMC research notes. 2015;8(1):815.CrossRefPubMedPubMedCentral
7.
Chen X, Yu B, Zhou D, Zhou W, Gong J, Li S, et al. A comparison of the number of men who have sex with men among rural-to-urban migrants with non-migrant rural and urban residents in Wuhan, China: a GIS/GPS-assisted random sample survey study. PLoS One. 2015;10(8):e0134712.CrossRefPubMedPubMedCentral
8.
Abaasa A, Nash S, Mayanja Y, Price M, Fast PE, Kamali A, et al. Simulated vaccine efficacy trials to estimate HIV incidence for actual vaccine clinical trials in key populations in Uganda. Vaccine. 2019;37(15):2065–72.CrossRefPubMed
9.
Seeley J, Nakiyingi-Miiro J, Kamali A, Mpendo J, Asiki G, Abaasa A, et al. High HIV incidence and socio-behavioral risk patterns in fishing communities on the shores of Lake Victoria, Uganda. Sex Transm Dis. 2012;39(6):433–9.CrossRefPubMed
10.
Ondondo RO, Ng’ang’a ZW, Mpoke S, Kiptoo M, Bukusi EA. Prevalence and incidence of HIV infection among fishermen along Lake Victoria Beaches in Kisumu County, Kenya; 2014.CrossRef
11.
Kasamba I, Nash S, Seeley J, Weiss HA. HIV incidence among women at high risk of HIV infection attending a dedicated clinic in Kampala, Uganda: 2008-2017. Sex Transm Dis. 2019;46(6):407–15.
12.
Vandepitte J, Weiss HA, Bukenya J, Nakubulwa S, Mayanja Y, Matovu G, et al. Alcohol use, Mycoplasma genitalium and other STIs associated with HIV incidence among women at high risk in Kampala, Uganda. J Acquir Immune Defic Syndr. 2013;62(1):119.CrossRefPubMedPubMedCentral
13.
Dubé K, Zango A, van de Wijgert J, Meque I, Ferro JJ, Cumbe F, et al. HIV incidence in a cohort of women at higher risk in Beira, Mozambique: prospective study 2009–2012. PLoS One. 2014;9(1):e84979.CrossRefPubMedPubMedCentral
14.
Abaasa A, Asiki G, Price MA, Ruzagira E, Kibengo F, Bahemuka U, et al. Comparison of HIV incidence estimated in clinical trial and observational cohort settings in a high risk fishing population in Uganda: implications for sample size estimates. Vaccine. 2016;34(15):1778–85.CrossRefPubMedPubMedCentral
15.
Kiwanuka N, Ssetaala A, Nalutaaya A, Mpendo J, Wambuzi M, Nanvubya A, et al. High incidence of HIV-1 infection in a general population of fishing communities around Lake VictoriaUganda. PloS one. 2014;9(5):e94932.CrossRefPubMedPubMedCentral
16.
Hladik W, Baughman AL, Serwadda D, Tappero JW, Kwezi R, Nakato ND, et al. Burden and characteristics of HIV infection among female sex workers in Kampala, Uganda–a respondent-driven sampling survey. BMC Public Health. 2017;17(1):565.CrossRefPubMedPubMedCentral
17.
Asiki G, Abaasa A, Ruzagira E, Kibengo F, Bahemuka U, Mulondo J, et al. Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda. Vaccine. 2013;31(44):5055–61.CrossRefPubMedPubMedCentral
18.
Kiwanuka N, Ssetaala A, Mpendo J, Wambuzi M, Nanvubya A, Sigirenda S, et al. High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda. J Int AIDS Soc. 2013;16(1):18621.CrossRefPubMedPubMedCentral
19.
Kiwanuka N, Mpendo J, Nalutaaya A, Wambuzi M, Nanvubya A, Kitandwe PK, et al. An assessment of fishing communities around Lake Victoria, Uganda, as potential populations for future HIV vaccine efficacy studies: an observational cohort study. BMC Public Health. 2014;14(1):986.CrossRefPubMedPubMedCentral
20.
Bahemuka UM, Abaasa A, Ruzagira E, Lindan C, Price MA, Kamali A, et al. Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda. PloS one. 2019;14(1):e0198460.CrossRefPubMedPubMedCentral
21.
Pinsky P, Miller A, Kramer B, Church T, Reding D, Prorok P, et al. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol. 2007;165(8):874–81.CrossRefPubMed
22.
Peterson L, Nanda K, Opoku BK, Ampofo WK, Owusu-Amoako M, Boakye AY, et al. SAVVY®(C31G) gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS One. 2007;2(12):e1312.CrossRefPubMedPubMedCentral
23.
Feldblum PJ, Adeiga A, Bakare R, Wevill S, Lendvay A, Obadaki F, et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One. 2008;3(1):e1474.CrossRefPubMedPubMedCentral
24.
Vandepitte J, Bukenya J, Weiss HA, Nakubulwa S, Francis SC, Hughes P, et al. HIV and other sexually transmitted infections in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda. Sex Transm Dis. 2011;38(4):316.PubMedPubMedCentral
25.
Ortner Hadžiabdić M, Mucalo I, Hrabač P, Matić T, Rahelić D, Božikov V. Factors predictive of drop-out and weight loss success in weight management of obese patients. J Hum Nutr Diet. 2015;28:24–32.CrossRefPubMed
26.
Marcus MW, Raji OY, Chen Y, Duffy SW, Field JK. Factors associated with dropout in a lung cancer high-risk cohort-the Liverpool lung project. Int J Oncol. 2014;44(6):2146–52.CrossRefPubMed
27.
Ruzagira E, Wandiembe S, Abaasa A, Bwanika AN, Bahemuka U, Amornkul P, et al. HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study. PLoS One. 2011;6(8):e24037.CrossRefPubMedPubMedCentral
28.
Mutagoma M, Samuel MS, Kayitesi C, Gasasira AR, Chitou B, Boer K, et al. High HIV prevalence and associated risk factors among female sex workers in Rwanda. Int J STD AIDS. 2017;28(11):1082–9.CrossRefPubMedPubMedCentral
29.
Abshire M, Dinglas VD, Cajita MIA, Eakin MN, Needham DM, Himmelfarb CD. Participant retention practices in longitudinal clinical research studies with high retention rates. BMC Med Res Methodol. 2017;17(1):30.CrossRefPubMedPubMedCentral
30.
31.
Graham SM, Raboud J, McClelland RS, Jaoko W, Ndinya-Achola J, Mandaliya K, et al. Loss to follow-up as a competing risk in an observational study of HIV-1 incidence. PLoS One. 2013;8(3):e59480.CrossRefPubMedPubMedCentral
32.
Albuquerque MFPM, Ximenes RAA, Lucena-Silva N, Souza WVD, Dantas AT, Dantas OMS, et al. Factors associated with treatment failure, dropout, and death in a cohort of tuberculosis patients in Recife, Pernambuco State, Brazil. Cad Saúde Pública. 2007;23:1573–82.CrossRef
33.
34.
Nunn AJ, Wagner H-U, Kamali A, Kengeya-Kayondo JF, Mulder DW. Migration and HIV-1 seroprevalence in a rural Ugandan population. Aids. 1995;9(5):503–6.CrossRefPubMed
Metadata
Title
Comparison of retention in observational cohorts and nested simulated HIV vaccine efficacy trials in the key populations in Uganda
Authors
Andrew Abaasa
Jim Todd
Stephen Nash
Yunia Mayanja
Pontiano Kaleebu
Patricia E. Fast
Matt Price
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2020
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-020-00920-4

Other articles of this Issue 1/2020

BMC Medical Research Methodology 1/2020 Go to the issue

Research article

Recruitment of adolescents with suicidal ideation in the emergency department: lessons from a randomized controlled pilot trial of a youth suicide prevention intervention

Research article

A computational method to quantitatively measure pediatric drug safety using electronic medical records

Technical advance

LEVEL (Logical Explanations & Visualizations of Estimates in Linear mixed models): recommendations for reporting multilevel data and analyses

Research article

Including non-concurrent control patients in the analysis of platform trials: is it worth it?

Research article

Homogeneity score test of AC1 statistics and estimation of common AC1 in multiple or stratified inter-rater agreement studies

Research article

Identifying the fundamental structures and processes of care contributing to emergency general surgery quality using a mixed-methods Donabedian approach